In vivo tumor xenograft experiments showed that knockdown of circZFR inhibited tumor growth and weakened DDP resistance, while CAFs-derived exosomes increased circZFR level, inhibited the STAT3/NF-κB pathway, promoted tumor growth and enhanced DDP resistance. The gene discussed is NFKB1; the disease is neoplasm.